Richard C. Sims, M.D. has been designated a Center of Excellence for the Intracept™ Procedure by Boston Scientific, the ...
The accepted paper, titled "Evaluation of Urcosimod in Neuropathic Corneal Pain: Efficacy and Safety Results from a Proof-of-Concept Pilot Phase 2 Study", will be presented in the Ocular Surface ...
Orphan Drug Designation applies to approximately 50,000 Patients who predominantly suffer from severe chronic pain due ...
A research-supported, seven-part system developed from clinical practice and Dr. Jacobs’ own healing journey Pain is ...
We are looking forward to continuing to provide the highest level of care to patients suffering from pain in southeast ...
The FDA endorsed a ≥2-point reduction on a visual analogue scale for pain as a clinically meaningful endpoint for urcosimod ...
Why a personal injury clinic, work injury treatment, arizona orthopedic, pain management, and spine injury treatment ...
DONGGUAN, GUANGDONG, CHINA, January 13, 2026 /EINPresswire.com/ -- Globally, the medical device industry is changing ...
3don MSN
From achy back to stiff knees... researchers discover key cause of chronic pain and how to cure it
For one in five Americans, chronic pain is inescapable. But a new study from the University of Colorado at Boulder points ...
A neural circuit hidden in an understudied region of the brain plays a critical role in turning temporary pain into pain that ...
A neural circuit hidden in an understudied region of the brain plays a critical role in turning temporary pain into pain that can last months or years, according to new University of Colorado Boulder ...
Abbott’s neuromodulation systems can significantly reduce pain-related healthcare visits for people living with chronic pain, according to five-year data.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results